Presented at The 2024 ACMG Annual Clinical Genetics Meeting by Genomenon Founder and Chief Scientific Officer, Mark Kiel, MD, PhD.
Presented at The 2024 ACMG Annual Clinical Genetics Meeting by Genomenon Founder and Chief Scientific Officer, Mark Kiel, MD, PhD.
